超过两百万使用GLP-1药物的加拿大人正在减少饮食，导致食品销售大幅减少，并重塑了食品经济。 Over two million Canadians using GLP-1 drugs are eating less, slashing food sales and reshaping the food economy.

200多万加拿大人正在使用Ozempic和Wegovy等GLP-1药品来减肥,导致粮食消费显著下降,粮食经济每年损失33亿美元。 Over two million Canadians are using GLP-1 medications like Ozempic and Wegovy for weight loss, leading to a significant drop in food consumption and a $3.3 billion annual loss in the food economy. 调查数据显示,大多数用户吃少、吃少、买少,导致零食、含糖饮料、烘烤食品和酒精销售急剧下降。 Survey data shows most users eat less, dine out less, and buy fewer groceries, causing sharp declines in sales of snacks, sugary drinks, baked goods, and alcohol. 零售商、制造商和农民正在适应,雀巢公司等公司正在推出GLP-1友好型产品。 Retailers, manufacturers, and farmers are adapting, with companies like Nestlé launching GLP-1-friendly products. 由长期药物使用和生理变化驱动的这一转变不是暂时的,正在改变加拿大各地的粮食需求,并反映了美国早期的趋势。 The shift, driven by long-term medication use and physiological changes, is not temporary and is reshaping food demand across Canada and mirroring early trends in the U.S.